HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, particularly the left ventricle. This thickening can impede the heart's ability to efficiently pump blood. HCM is often hereditary, and individuals with a family history of the condition are at an increased risk. While some people with HCM may experience no symptoms, others may suffer from chest pain, shortness of breath, or fatigue. In severe cases, HCM can lead to abnormal heart rhythms and an increased risk of sudden cardiac arrest. Diagnosis typically involves a combination of medical history, physical examinations, and diagnostic tests such as echocardiograms. Treatment options aim to alleviate symptoms and may include medications, lifestyle modifications, or, in extreme cases, surgical procedures. Regular monitoring and follow-up with healthcare providers are crucial for managing HCM and preventing complications.

Committee Members
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Sergey Suchkov

Sergey Suchkov

N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Tags

Submit your abstract Today

Watsapp